DUBLIN--(BUSINESS WIRE)--The "Continuous Glucose Monitoring Systems Market by Components, Demographics, and Adult Population, and End User - Global Opportunity Analysis and Industry Forecast, 2016-2024" report has been added to ResearchAndMarkets.com's offering.
The global CGMS market generated $894 million in 2016, and is projected to reach $4,921 million by 2024, registering a CAGR of 22.9% during the forecast period. The pipeline of high-tech CGMS devices, such as smartphone-connected CGMS, wearable & smartphone-connected CGMS, non-invasive CGMS and smart' diabetes management solution (also called artificial/bionic pancreas), is expected to result in higher adoption of CGMS among endocrinologists and patients.
Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in diabetes management, owing to their associated several advantages over other glucose monitoring devices. Unlike conventional glucose monitors, these systems enable periodic monitoring of glucose levels, which is crucial for avoiding diabetic complications. In addition, CGMS technology has laid a roadmap to the most awaited, high-tech, closed-loop artificial/bionic pancreas.
The market is categorized based on component, demographics, end user, and region. The CGMS components market includes durable components such as transmitters & receivers and integrated insulin pumps; and disposable components such as sensors. The segment for sensors occupies a dominant share in the CGMS market due to recurring sales of CGMS, short scrap life, and bulk purchases. Therefore, it is deployed in diagnostic centers/clinics.
- Abbott Laboratories
- Dexcom, Inc.
- A. Menarini Diagnostics
- Echo Therapeutics, Inc.
- Insulet Corporation
- GlySens Incorporated
- Johnson & Johnson
- Medtronic plc
- Senseonics Holdings, Inc.
- F. Hoffmann-La Roche Ltd.
Key Topics Covered:
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: Continous Glucose Monitoring Systems Market, By Component
Chapter 5: Continuous Glucose Monitoring Systems Market, By Demographics
Chapter 6: Continuous Glucose Monitoring Systems Market, By End User
Chapter 7: Continuous Glucose Monitoring Systems Market, By Region
Chapter 8: Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/wcrblj/global_continuous?w=4